Therapy‐related Ph+ leukemia after both bone marrow and mesenchymal stem cell transplantation for hypophosphatasia
暂无分享,去创建一个
T. Taketani | S. Mishima | S. Yuba | S. Fukuda | S. Yamaguchi | M. Tadokoro | Y. Katsube | R. Kanai | Mariko Abe | H. Ogushi | S. Yamaguchi | Yoshihiro Katsube
[1] R. Tuan,et al. Regulation of stemness and stem cell niche of mesenchymal stem cells: Implications in tumorigenesis and metastasis , 2010, Journal of cellular physiology.
[2] M. Czader,et al. Therapy-related myeloid neoplasms. , 2009, American journal of clinical pathology.
[3] T. Taketani,et al. New bone formation by allogeneic mesenchymal stem cell transplantation in a patient with perinatal hypophosphatasia. , 2009, The Journal of pediatrics.
[4] M. Kassem,et al. The use of mesenchymal (skeletal) stem cells for treatment of degenerative diseases: Current status and future perspectives , 2009, Journal of cellular physiology.
[5] A. Hagemeijer,et al. Rare recurring balanced chromosome abnormalities in therapy‐related myelodysplastic syndromes and acute leukemia: Report from an International Workshop † , 2002, Genes, chromosomes & cancer.
[6] C. Waller,et al. Treatment-related chronic myelogenous leukemia , 1999, Annals of Hematology.
[7] B. Johansson,et al. Chemotherapy-related – and late occurring – Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors? , 1997, Leukemia.
[8] Kazuya Sato,et al. Mesenchymal stromal cells for graft-versus-host disease : basic aspects and clinical outcomes. , 2010, Journal of clinical and experimental hematopathology : JCEH.
[9] N. Emi,et al. Chronic myeloid leukemia following chemotherapy with 5'-deoxy-5-fluorouridine for gastric cancer. , 2008, Internal medicine.